MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 592002 | Name: Nicotinic anhydride
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Nicotinic anhydride is a biochemical.

Chemical Structure

Nicotinic anhydride
CAS#16837-38-0

Theoretical Analysis

MedKoo Cat#: 592002

Name: Nicotinic anhydride

CAS#: 16837-38-0

Chemical Formula: C12H8N2O3

Exact Mass: 228.0535

Molecular Weight: 228.21

Elemental Analysis: C, 63.16; H, 3.53; N, 12.28; O, 21.03

Price and Availability

Size Price Availability Quantity
1g USD 260.00 2 Weeks
5g USD 695.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Nicotinic anhydride; AI3-15770; AI3 15770; AI315770
IUPAC/Chemical Name
3-Pyridinecarboxylic acid, anhydride
InChi Key
VPODXHOUBDCEHN-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H8N2O3/c15-11(9-3-1-5-13-7-9)17-12(16)10-4-2-6-14-8-10/h1-8H
SMILES Code
O=C(OC(C1=CC=CN=C1)=O)C2=CC=CN=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Product Data
Instruction
View handling instruction
Biological target:
Nicotinic anhydride is a biochemical.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 228.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Menzel C, Silbernagl J, Laffleur F, Leichner C, Jelkmann M, Huck CW, Hussain S, Bernkop-Schnürch A. 2,2'Dithiodinicotinyl ligands: Key to more reactive thiomers. Int J Pharm. 2016 Apr 30;503(1-2):199-206. doi: 10.1016/j.ijpharm.2016.03.010. Epub 2016 Mar 10. PubMed PMID: 26972378. 2: Longstreet AR, Campbell BS, Gupton BF, McQuade DT. Improved synthesis of mono- and disubstituted 2-halonicotinonitriles from alkylidene malononitriles. Org Lett. 2013 Oct 18;15(20):5298-301. doi: 10.1021/ol4025265. Epub 2013 Oct 4. PubMed PMID: 24093933. 3: Nakamura T, Chu X, Shimasaki T, Shibata M. Organogelation behavior and thermal properties of supramolecular polymer network composed of carboxy- and pyridyl-terminated 4-arm star-shaped ε-caprolactone oligomers. J Colloid Interface Sci. 2013 Aug 15;404:8-15. doi: 10.1016/j.jcis.2013.04.039. Epub 2013 May 1. PubMed PMID: 23684230. 4: Qi H, Liu X, Zhang J, Duan Y, Wang X, Zhang Q. Synthesis and antihyperlipidemic activity of acetylated derivative of ulvan from Ulva pertusa. Int J Biol Macromol. 2012 Jan 1;50(1):270-2. doi: 10.1016/j.ijbiomac.2011.11.006. Epub 2011 Nov 17. PubMed PMID: 22115715. 5: Györgydeák Z, Hadady Z, Felföldi N, Krakomperger A, Nagy V, Tóth M, Brunyánszki A, Docsa T, Gergely P, Somsák L. Synthesis of N-(beta-D-glucopyranosyl)- and N-(2-acetamido-2-deoxy-beta-D-glucopyranosyl) amides as inhibitors of glycogen phosphorylase. Bioorg Med Chem. 2004 Sep 15;12(18):4861-70. PubMed PMID: 15336265. 6: Hsieh MT, Wu CR, Lin LW, Hsieh CC, Tsai CH. Reversal caused by n-butylidenephthalide from the deficits of inhibitory avoidance performance in rats. Planta Med. 2001 Feb;67(1):38-42. PubMed PMID: 11270720. 7: Testai FD, Venera GD, Pena C, de Jimenez Bonino MJ. Histidine 186 of the nicotinic acetylcholine receptor alpha subunit requires the presence of the 192-193 disulfide bridge to interact with alpha-bungarotoxin. Neurochem Int. 2000 Jan;36(1):27-33. PubMed PMID: 10566956. 8: Coates PA, Blagbrough IS, Rowan MG, Pearson DP, Lewis T, Potter BV. Preliminary synthetic studies of methyllycaconitine, a potent nicotinic acetylcholine receptor antagonist: rapid syntheses of AE-bicyclic analogues. J Pharm Pharmacol. 1996 Feb;48(2):210-3. PubMed PMID: 8935174. 9: Gabor F, Hamilton G, Pittner F. Drug-protein conjugates: haptenation of 1-methyl-10 alpha-methoxydihydrolysergol and 5-bromonicotinic acid to albumin for the production of epitope-specific monoclonal antibodies against nicergoline. J Pharm Sci. 1995 Sep;84(9):1120-5. PubMed PMID: 8537892. 10: Brewster ME, Druzgala PJ, Anderson WR, Huang MJ, Bodor N, Pop E. Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting. J Pharm Sci. 1995 Jan;84(1):38-43. PubMed PMID: 7714741. 11: Ewalt KL. Extracytoplasmic disposition of lysine beta 165 of acetylcholine receptor. Biochemistry. 1994 May 3;33(17):5077-88. PubMed PMID: 8172883. 12: Lacorazza HD, Otero de Bengtsson MS, Biscoglio de Jiménez Bonino M. Role of histidine residues in the alpha-bungarotoxin binding site of the nicotinic acetylcholine receptor. Neurochem Int. 1992 Jun;20(4):521-7. PubMed PMID: 1304868. 13: Pop E, Prókai-Tátrai K, Scott JD, Brewster ME, Bodor N. Application of a brain-targeting chemical delivery system to 9-amino-1,2,3,4-tetrahydroacridine. Pharm Res. 1990 Jun;7(6):658-64. PubMed PMID: 2367335. 14: Stein ML, Nencini P. Dimethyl cathate: synthesis and pharmacological investigation. Farmaco. 1989 Oct;44(10):959-65. PubMed PMID: 2619861. 15: Eckstein M, Misztal S, Terczyńska A, Sienkiewicz B, Roszkowski A, Adamus M. Synthesis of N-nicotinoyl-tryptamine (tryptamide). Pol J Pharmacol Pharm. 1987 Nov-Dec;39(6):725-7. PubMed PMID: 2972997. 16: Hassan E, Al-Ashmawi MI, Abd El-Fattah B. Synthesis and antimicrobial testing of certain oxadiazoline and triazole derivatives. Pharmazie. 1983 Dec;38(12):833-5. PubMed PMID: 6669612. 17: Eriksson H, Liljeqvist G, Heilbronn E. Extraction of peripheral proteins from nicotinic acetylcholine receptor-enriched membranes. Biochim Biophys Acta. 1983 Mar 9;728(3):449-54. PubMed PMID: 6824668. 18: Tortolani G. [Determination of amidopyrine, nicotinate of guaiacyl-ortho-hydroxybenzoate and lidocaine hydrochloride by differential potentiometric titration in a non-aqueous medium]. Farmaco Prat. 1974 May;29(5):272-7. Italian. PubMed PMID: 4846082. 19: Kung HF, Cederbaum S, Tsai L, Stadtman TC. Nicotinic acid metabolism. V. A cobamide coenzyme-dependent conversion of alpha-methyleneglutaric acid to dimethylmaleic acid. Proc Natl Acad Sci U S A. 1970 Apr;65(4):978-84. PubMed PMID: 5266166; PubMed Central PMCID: PMC283012. 20: Fleming I, Mason JB. A product from the reaction of pyridine with acetic anhydride. J Chem Soc Perkin 1. 1969;18:2509-10. PubMed PMID: 5391296.

View History

CEP

CEP